{"version":"company-facts.v1","source":"https://secwatch.observer","generated_at":"2026-06-05T16:06:24.110619+00:00","company":{"ticker":"SOLV","cik":1964738,"company_name":"Solventum Corp"},"pagination":{"limit":100,"returned":16,"next_cursor":null},"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer","facts":[{"fact_type":"earnings_release","fact_key":"b3aba74aec2754db92206a268d507bd275b3be7a","cik":1964738,"ticker":"SOLV","company_name":"Solventum Corp","filed_at":"2026-05-05T23:59:59+00:00","payload":{"eps_text":"$0.07","guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":"$13 million","period_text":"first quarter ended March 31, 2026","report_date":"2026-05-05","result_type":"reported_results","revenue_text":"$2,007 million"},"claim":"Solventum Corp reported first quarter ended March 31, 2026 results: revenue $2,007 million, net income $13 million, EPS $0.07. Guidance reaffirmed.","evidence_excerpt":"range EAGAN, Minn., May 5, 2026 – Solventum (NYSE: SOLV) today reported financial results for the first quarter ended March 31, 2026. First Quarter 2026 Highlights • S ales of $2.0 billion decreased (3.0)% on a reported basis; an increase of 2.1% on an organic basis • G AAP diluted earnings per share of $0.07; adjusted diluted earnings per share of $1.48, a 10.6%","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001964738-26-000022","anchor_url":"https://secwatch.observer/filing/0001964738-26-000022#claim-b3aba74aec2754db92206a268d507bd275b3be7a","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1964738/000196473826000022/0001964738-26-000022-index.htm"},{"fact_type":"ma_transaction","fact_key":"903ad3b3330a5df430ea76c9666d931ab5f8b474","cik":1964738,"ticker":"SOLV","company_name":"Solventum Corp","filed_at":"2025-09-02T23:59:59+00:00","payload":{"action":"disposition","closing_date":"2025-09-01","consideration_text":"approximately $4.0 billion","counterparty":"Thermo Fisher Scientific Inc.","effective_date":"2025-09-01","item_codes_triggered":["2.01"]},"claim":"Solventum Corp completed a disposition involving Thermo Fisher Scientific Inc. for approximately $4.0 billion (closed 2025-09-01).","evidence_excerpt":"Solventum completed the sale of the Business to the Buyer in accordance with the terms of the Agreement. The cash consideration paid to Solventum at closing was approximately $4.0 billion, which is subject to further adjustments for closing cash and indebtedness, unpaid transaction expenses and working capital as set forth in the Agreement, as well as a payment to","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001964738-25-000078","anchor_url":"https://secwatch.observer/filing/0001964738-25-000078#claim-903ad3b3330a5df430ea76c9666d931ab5f8b474","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1964738/000196473825000078/0001964738-25-000078-index.htm"},{"fact_type":"earnings_release","fact_key":"17d3bc4d5669c3158002a0c7b9b486800dd84d15","cik":1964738,"ticker":"SOLV","company_name":"Solventum Corp","filed_at":"2024-05-09T23:59:59+00:00","payload":{"eps_text":"$1.37","guidance_signal":"reaffirmed","item_codes_triggered":["2.02"],"net_income_text":null,"period_text":"the first quarter ended March 31, 2024","report_date":"2024-05-09","result_type":"reported_results","revenue_text":"$2.016 billion"},"claim":"Solventum Corp reported the first quarter ended March 31, 2024 results: revenue $2.016 billion, EPS $1.37. Guidance reaffirmed.","evidence_excerpt":"Reports First Quarter 2024 Financial Results and Capital Allocation Update • Completed spin-off from 3M and began trading on April 1, 2024 • Reported sales increased 0.2% to $2.016 billion, organic sales increased 0.9% • GAAP Earnings Per Share (EPS) of $1.37; adjusted EPS 1 of $2.08 • Generated $442 million of cash from operations; free cash flow 1 of $340 million","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001964738-24-000012","anchor_url":"https://secwatch.observer/filing/0001964738-24-000012#claim-17d3bc4d5669c3158002a0c7b9b486800dd84d15","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1964738/000196473824000012/0001964738-24-000012-index.htm"},{"fact_type":"executive_change","fact_key":"cc27cff531","cik":1964738,"ticker":"SOLV","company_name":"Solventum Corp","filed_at":"2024-04-16T23:59:59+00:00","payload":{"action":"elected","action_category":"appointment","departure_tone":"not_applicable","effective_date":"2024-04-12","interim":false,"role":"Director","role_category":"director","successor_name":null,"successor_named":false},"claim":"Shirley A. Edwards was elected as Director at Solventum Corp.","evidence_excerpt":"On April 12, 2024, the Board of Directors (the “Board”) of Solventum Corporation (the “Company”) elected Shirley A. Edwards to the Company’s Board, effective April 12, 2024.","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001964738-24-000010","anchor_url":"https://secwatch.observer/filing/0001964738-24-000010#claim-cc27cff531","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1964738/000196473824000010/0001964738-24-000010-index.htm"},{"fact_type":"governance_change","fact_key":"acdb105364d36d2b48b3bb2e3b7a02d9857aebbc","cik":1964738,"ticker":"SOLV","company_name":"Solventum Corp","filed_at":"2024-04-04T23:59:59+00:00","payload":{"change_type":"code_of_ethics","effective_date":null,"item_codes_triggered":["5.05"],"summary_text":"Adoption of Corporate Governance Guidelines and Board of Directors Code of Business Conduct and Ethics"},"claim":"Solventum Corp: Adoption of Corporate Governance Guidelines and Board of Directors Code of Business Conduct and Ethics.","evidence_excerpt":"In connection with the Distribution, the Board adopted Corporate Governance Guidelines and a Board of Directors Code of Business Conduct and Ethics, effective as of the Effective Time.","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-24-014887","anchor_url":"https://secwatch.observer/filing/0001628280-24-014887#claim-acdb105364d36d2b48b3bb2e3b7a02d9857aebbc","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm"},{"fact_type":"governance_change","fact_key":"b7b5e073ed3d7a0f0fade95d8c9349a438517732","cik":1964738,"ticker":"SOLV","company_name":"Solventum Corp","filed_at":"2024-04-04T23:59:59+00:00","payload":{"change_type":"bylaw_amendment","effective_date":"2024-03-31","item_codes_triggered":["5.03"],"summary_text":"Amended and restated Bylaws effective March 31, 2024"},"claim":"Solventum Corp: Amended and restated Bylaws effective March 31, 2024 (effective 2024-03-31).","evidence_excerpt":"immediately thereafter, amended and restated its Bylaws (the “Amended and Restated Bylaws”)","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-24-014887","anchor_url":"https://secwatch.observer/filing/0001628280-24-014887#claim-b7b5e073ed3d7a0f0fade95d8c9349a438517732","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm"},{"fact_type":"governance_change","fact_key":"b08635f62dbe5a3f4e1a10893a2077ee26b46135","cik":1964738,"ticker":"SOLV","company_name":"Solventum Corp","filed_at":"2024-04-04T23:59:59+00:00","payload":{"change_type":"charter_amendment","effective_date":"2024-03-31","item_codes_triggered":["5.03"],"summary_text":"Amended and restated Certificate of Incorporation effective March 31, 2024"},"claim":"Solventum Corp: Amended and restated Certificate of Incorporation effective March 31, 2024 (effective 2024-03-31).","evidence_excerpt":"Effective as of 3:30 a.m. Eastern Time on March 31, 2024, Solventum amended and restated its Certificate of Incorporation (the “Amended and Restated Certificate of Incorporation”)","confidence":0.9,"filing_url":"https://secwatch.observer/filing/0001628280-24-014887","anchor_url":"https://secwatch.observer/filing/0001628280-24-014887#claim-b08635f62dbe5a3f4e1a10893a2077ee26b46135","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm"},{"fact_type":"material_agreement","fact_key":"2bfbed701cc68174842cb84a2da4f916e2098ef8","cik":1964738,"ticker":"SOLV","company_name":"Solventum Corp","filed_at":"2024-04-04T23:59:59+00:00","payload":{"action":"entry","agreement_name":"Separation and Distribution Agreement and related agreements","agreement_type":"supply","counterparty":"3M Company","effective_date":"2024-03-31","item_codes_triggered":["1.01"],"value_text":"Entry into multiple separation-related agreements including Separation and Distribution Agreement, T"},"claim":"Solventum Corp entered into Separation and Distribution Agreement and related agreements with 3M Company valued at Entry into multiple separation-related agreements including Separation and Distribution Agreement, T (effective 2024-03-31).","evidence_excerpt":"On March 31, 2024, Solventum Corporation (“Solventum”) entered into several agreements with 3M Company (“3M”) in connection with the spin-off of 3M’s health care business (the “Separation”) through the pro rata distribution of 80.1% of the issued and outstanding shares of common stock, par value $0.01 per share, of Solventum to 3M’s stockholders of record as of the close of business on March 18, 2024 (the “Distribution”).","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-24-014887","anchor_url":"https://secwatch.observer/filing/0001628280-24-014887#claim-2bfbed701cc68174842cb84a2da4f916e2098ef8","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm"},{"fact_type":"executive_change","fact_key":"63f3a7d7d2","cik":1964738,"ticker":"SOLV","company_name":"Solventum Corp","filed_at":"2024-04-04T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":null,"interim":false,"role":"Chief Human Resources Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Tammy Gomez was appointed as Chief Human Resources Officer at Solventum Corp.","evidence_excerpt":"Tammy Gomez Chief Human Resources Officer","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-24-014887","anchor_url":"https://secwatch.observer/filing/0001628280-24-014887#claim-63f3a7d7d2","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm"},{"fact_type":"executive_change","fact_key":"15e280dfbf","cik":1964738,"ticker":"SOLV","company_name":"Solventum Corp","filed_at":"2024-04-04T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":null,"interim":false,"role":"Chief Supply Chain Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Paul Harrington was appointed as Chief Supply Chain Officer at Solventum Corp.","evidence_excerpt":"Paul Harrington Chief Supply Chain Officer","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-24-014887","anchor_url":"https://secwatch.observer/filing/0001628280-24-014887#claim-15e280dfbf","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm"},{"fact_type":"executive_change","fact_key":"74bc333dc3","cik":1964738,"ticker":"SOLV","company_name":"Solventum Corp","filed_at":"2024-04-04T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":null,"interim":false,"role":"Chief Information and Digital Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Amy Landucci was appointed as Chief Information and Digital Officer at Solventum Corp.","evidence_excerpt":"Amy Landucci Chief Information and Digital Officer","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-24-014887","anchor_url":"https://secwatch.observer/filing/0001628280-24-014887#claim-74bc333dc3","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm"},{"fact_type":"executive_change","fact_key":"89c4113390","cik":1964738,"ticker":"SOLV","company_name":"Solventum Corp","filed_at":"2024-04-04T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":null,"interim":false,"role":"Executive Vice President and Group President, Medical Solutions","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Chris Barry was appointed as Executive Vice President and Group President, Medical Solutions at Solventum Corp.","evidence_excerpt":"Chris Barry Executive Vice President and Group President, Medical Solutions","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-24-014887","anchor_url":"https://secwatch.observer/filing/0001628280-24-014887#claim-89c4113390","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm"},{"fact_type":"executive_change","fact_key":"69740a443e","cik":1964738,"ticker":"SOLV","company_name":"Solventum Corp","filed_at":"2024-04-04T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":null,"interim":false,"role":"Senior Vice President, Controller and Chief Accounting Officer","role_category":"other_named_officer","successor_name":null,"successor_named":false},"claim":"Mary Wilcox was appointed as Senior Vice President, Controller and Chief Accounting Officer at Solventum Corp.","evidence_excerpt":"Mary Wilcox Senior Vice President, Controller and Chief Accounting Officer","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-24-014887","anchor_url":"https://secwatch.observer/filing/0001628280-24-014887#claim-69740a443e","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm"},{"fact_type":"executive_change","fact_key":"25f8083906","cik":1964738,"ticker":"SOLV","company_name":"Solventum Corp","filed_at":"2024-04-04T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":null,"interim":false,"role":"Chief Legal Affairs Officer, Corporate Secretary","role_category":"general_counsel","successor_name":null,"successor_named":false},"claim":"Marcela Kirberger was appointed as Chief Legal Affairs Officer, Corporate Secretary at Solventum Corp.","evidence_excerpt":"Marcela Kirberger Chief Legal Affairs Officer, Corporate Secretary","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-24-014887","anchor_url":"https://secwatch.observer/filing/0001628280-24-014887#claim-25f8083906","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm"},{"fact_type":"executive_change","fact_key":"935eee1122","cik":1964738,"ticker":"SOLV","company_name":"Solventum Corp","filed_at":"2024-04-04T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":null,"interim":false,"role":"Chief Financial Officer","role_category":"cfo","successor_name":null,"successor_named":false},"claim":"Wayde McMillan was appointed as Chief Financial Officer at Solventum Corp.","evidence_excerpt":"Wayde McMillan Chief Financial Officer","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-24-014887","anchor_url":"https://secwatch.observer/filing/0001628280-24-014887#claim-935eee1122","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm"},{"fact_type":"executive_change","fact_key":"7b578cccf5","cik":1964738,"ticker":"SOLV","company_name":"Solventum Corp","filed_at":"2024-04-04T23:59:59+00:00","payload":{"action":"appointed","action_category":"appointment","departure_tone":"not_applicable","effective_date":null,"interim":false,"role":"Chief Executive Officer","role_category":"ceo","successor_name":null,"successor_named":false},"claim":"Bryan Hanson was appointed as Chief Executive Officer at Solventum Corp.","evidence_excerpt":"Bryan Hanson Chief Executive Officer","confidence":0.95,"filing_url":"https://secwatch.observer/filing/0001628280-24-014887","anchor_url":"https://secwatch.observer/filing/0001628280-24-014887#claim-7b578cccf5","edgar_index_url":"https://www.sec.gov/Archives/edgar/data/1964738/000162828024014887/0001628280-24-014887-index.htm"}]}